The ZyprexaKills wiki has issued a call for editorial submissions:
We are requesting submissions for editorials and op-eds about this issue
(500-750 words, maximum). Please send all submissions to zyprexa-discuss at
acm.jhu.edu, or create a new page in this wiki, and link to it from this one.
Ideas for possible op-ed topics include:
The importance of the "prior restraint" doctrine in the First Amendment
The effects of omniscient surveillance on whistleblowing
The growing threat of soft censorship, and the incongruity between outrage
at overt oppressive censorship and the complacency for the form it takes in a
modern liberal democracy.
The relationship between anonymity and freedom of speech
Critiques of the psychiatric medical model of mental illness
A call for pharmaceutical companies to pledge the equivalent of the
Hippocratic oath, so they are answerable to something other than the bottom
Advocating for a pro-choice position towards psychopharmaceuticals, not the
paternalistic, Big Daddy Pharma (and Mama Lilly) knows best
The dangers of sales people hawking dangerous, psychiatric medication to
general internists, even if its on-label
The slippery slope of zyprexa prescriptions and usage
The rationale behind FDA regulations and reviews of pharmaceutical marketing
The dangers of off-label marketing of drugs
Corporate responsibility and culpable negligence
The abuse of Medicare by predatory pricing practices
This story is about to get really big, and we have a rare opportunity to
present these issues to a very wide audience. Many people on this list may have
existing material that they may wish to re-purpose for this occasion.
Please circulate this message widely.
- Fletch Lives
It's here! Your new message!
Get new email alerts with the free Yahoo! Toolbar.
Zyprexa-discuss mailing list